The advent of high-density recording technologies, such as Neuropixels and large-scale calcium imaging, has provided an unprecedented look into the ...

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

Large language models and small language models will play different roles in ensuring that we deliver valuable generative AI applications at cost-effective levels. Generative AI applications revolve ...

Artificial intelligence is no longer confined to data crunching and automation; it's making profound inroads into the creative industries. Generative models like generative adversarial networks (GANs) ...

The wide availability of tools to build generative AI has led to a Cambrian explosion of startups in the space. Plentiful capital hasn’t hurt, either — nor has the declining cost of the requisite ...

The safest, most creator-first AI platform—built to protect likeness, intellectual property, and enterprise-grade content at scale.

According to MarketsandMarkets™, the Generative AI Server Market is expected to reach USD 448.60 billion by 2030 from USD 103.92 billion in 2025, registering a CAGR of 34.0% during the forecast period ...

Government agencies on both sides of the Atlantic are warning that artificial intelligence is accelerating the speed, scale, ...